Development of electrochemical labelling procedures using MEK extracted99mTc

Electrolytic labelling procedures have been reported for various^99mTc radiopharmaceuticals which differ widely in the choice of the electrodes, working pH, applied voltage and the quantity of current passed. The authors have studied the electrolytic labelling of^99mTc EHDP, gluconate and glucoheptonate with MEK extracted^99mTc using tin electrodes under different experimental conditions. The results have, shown that these compounds can be efficiently labelled with^99mTc in a single step procedure avoiding multiple pH adjustments. Labelling of human serum albumin microspheres suitable for lung imaging with^99mTc by the electrolytic method is also reported.     

Direct labelling of anti-gastric cancer monoclonal antibody 3H11 with99mTc

Monoclonal antibody 3H11 was labelled with^99mTc by modified Schwartz method. The antibody was incubated in a glass test tube at room temperature for 30min with a 1000-fold molar excess of 2-mercaptoethanol. The mean labelling efficiency of 3H11 with^99mTc was more than 95%. The immuonreactivity of^99mTc-3H11 was more than 80% by ELISA's method. Competetion results in vitro and HPLC analysis showed that^99mTc was combined at the high affinity sites of antibody. The biodistribution in nude mice bearing 823 gastric cancer xenograpfts showed that the radioactivity in tumor at 24h postinjection was the highest except for that in kidney. The tumor uptake was 8.98±2.42% i.d/g. The ratio of tumor to blood was over 1.5 and that of tumor to liver was more than 2.5 at 24h post-injection. The tumor was clearly imaged at 22h postinjection. The inital clinical results showed that^99mTc-3H11 was stable in vivo and was good located at the lesion sites.     

Synthesis and evaluation of analogues of HYNIC as bifunctional chelators for technetium

6-Hydrazinonicotinic acid (HYNIC, 1) is a well-established bifunctional technetium-binding ligand often used to synthesise bioconjugates for radiolabelling with Tc-99m. It is capable of efficient capture of technetium at extremely low concentrations, but the structure of the labelled complexes is heterogeneous and incompletely understood. In particular, it is of interest to determine whether, at the no-carrier-added level, it acts in a chelating or non-chelating mode. Here we report two new isomers of HYNIC: 2-hydrazinonicotinic acid (2-HYNIC, 2), which (like 1) is capable of chelation through the mutually ortho hydrazine and pyridine nitrogens and 4-hydrazinonicotinic acid (4-HYNIC, 3), which is not (due to the para-relationship of the hydrazine and pyridine nitrogens). LC-MS shows that the coordination chemistry of 2 with technetium closely parallels that of conventional 1, and no advantages of one over the other in terms of potential labelling efficiency or isomerism were discernable. Both 1 and 2 formed complexes with the loss of 5 protons from the ligand set, whether the co-ligand was tricine or EDDA. Ligand 3, however, failed to complex technetium except at very high ligand concentration: the marked contrast with 1 and 2 suggests that chelation, rather than nonchelating coordination, is a key feature of technetium coordination by HYNIC. Two further new HYNIC analogues, 2-chloro-6-hydrazinonicotinic acid (2-chloro-HYNIC, 4a) and 2,6-dihydrazinonicotinic acid (diHYNIC, 5) were also synthesised. The coordination chemistry of 4a with technetium was broadly parallel to that of 1 and 2 although it was a less efficient chelator, while 5 also behaved as an efficient chelator of technetium, but its coordination chemistry remains poorly defined and requires further investigation before it can sensibly be adopted for (99m)Tc-labelling. The new analogues 4a and 5 present an opportunity to develop trifunctional HYNIC analogues for more complex bioconjugate synthesis.     

In vitro kinetics of red blood cell labelling with99mTc in association with stannous pyrophosphate

The half time for the^99mTc labelling of red blood cells which have been pretreated with stannous pyrophosphate is determined in an in vitro system and shown to be approximately 5 minutes.     

Trifluoroacetyl as a protecting group for HYNIC: stability in the presence of electrophiles and application in the synthesis of Tc-radiolabelled peptides

TrifluoroacetylHYNIC-peptides have recently been shown to label directly with ^99mTc as efficiently as their non-trifluoroacetylated analogs. In this work, the trifluoroacetyl (Tfa) moiety has been evaluated as a protecting group for HYNIC against reaction with strong electrophiles. Fmoc-(trifluoroacetylHYNIC)-lysine, the chosen model starting material, was found to be resistant against acetaldehyde and benzylchloroformate challenges, at 1 mol equiv and a 1000 M excess, respectively. In contrast, the Fmoc-(HYNIC)-lysine derivative, with a free hydrazine group, was quantitatively converted to the corresponding hydrazone after a 1 h incubation with acetaldehyde. Fmoc-(trifluoroacetylHYNIC)-lysine was also found to be stable over a wide pH range (3.6-10) to the acetaldehyde challenge. High efficiency ^99mTc-radiolabelling (99%) was achieved in the presence of acetaldehyde using Fmoc-(trifluoroacetylHYNIC)-lysine, as compared to a poor radiolabelling yield (34%) obtained with the non-trifluoroacetylated analog. These findings firmly establish the trifluoroacetyl group as a convenient and effective protecting group for HYNIC, and as a promising alternative to currently available labelling strategies.     

Separation of99mTc from parent99Mo by solid-phase column extraction as a simple option for a new99mTc generator concept

Evidence is obtained to show that the liquidliquid extraction separation of^99mTc from⁹⁹Mo with methyl ethyl ketone, methyl propyl ketone and methyl isobutyl ketone can be transformed into a solid-phase column extraction procedure. The aqueous alkaline⁹⁹molybdate solution is immobilized on a column of a granular large-pore diatomaceous earch support, which is the neluted with the abovementioned extractants. Rapid and clean separation of^99mTc can be with all three solvents. The^99mTc can be back-extracted from the organic phase on a column filled with distilled water /or saline/ loaded granular diatomaceous earth /Extrelut^®/. The possibility of using the abovementioned procedure as a basis for a new^99mTc/⁹⁹Mo generator concept is envisaged.     

Investigation of isomer formation upon coordination of bifunctional histidine analogues with 99mTc/Re(CO)3

Histidine is a convenient tridentate chelator used in the synthesis of technetium-99m radiopharmaceuticals, as it can be pendantly attached to a biomolecule for molecular imaging applications. Once coordinated, it forms a neutral complex that is capable of forming diastereomers at the alpha amine of the histidine. This is demonstrated through the synthesis and characterization of four different histidine chelators; three small molecule chelators, which consist of a benzylated histidine at the alpha amine, and one modified dipeptide, containing a phenylalanine derivative at the C-terminus and a histidine at the N-terminus. Upon rhenium coordination, two products are observed, each having the desired exact mass of the metal-containing species. The two products have been characterized through LC-MS, (1)H, gCOSY, NOESY and ROESY NMR experiments, and the relative stereochemistry determined. The implications of diastereomer formation when using this chelation system for creating molecular imaging agents is also discussed.     

Preparation of salicylidene-aminates labeled with99mTc

A series of bidentate and tetradentate ligands with azomethine and Ar–OH functional groups derived from salicylaldehyde and primary alkyl or aryl monoamines and diamines has been synthesized and labeled with^99mTc at various pH's using stannous chloride as reducing agent. The labeling efficiency was monitored by thin layer and paper chromatography.     

99mTc-centered one-pot synthesis for preparation of 99mTc radiotracers

Nuclear medicine relies on two main imaging modalities: single photon emission computed tomography (SPECT) and positron emission tomography (PET). Radiopharmaceuticals (or radiotracers) are the blood stream of nuclear medicine for the diagnosis or therapy of diseases. Diagnostic radiotracers that are small molecules labelled with a gamma-emitter for SPECT or positron-emitter for PET provide a non-invasive method to assess the disease or disease states and monitor the therapeutic efficacy of a specific treatment regime. Over the past four decades, radiopharmaceutical research has been practising one-pot synthesis at the tracer level (10(-7)-10(-6) M). Many (99m)Tc radiotracers currently used in nuclear medicine are routinely prepared by following the basic principles of one-pot synthesis. Unlike traditional organic one-pot synthesis, which often involves the formation of multiple C-C and C-heteroatom bonds in a single step, the (99m)Tc-centered one-pot synthesis requires the formation of multiple coordination bonds between Tc and various donor atoms, such as N, O, S and P. This review will illustrate how the (99m)Tc-centered one-pot synthesis is utilized for routine preparations of different (99m)Tc radiotracers.     

A novel technique for the separation of99mTc from99Mo

A new technique for the separation of^99mTc from low specific activity⁹⁹Mo is reported. A separation based on the principle of precipitation of⁹⁹Mo as calcium molybdate has been investigated. On precipitating⁹⁹MoO ₄ ^2– from alkaline solution as calcium molybdate under controlled conditions, the^99mTcO ₄ ^– is found to remain quantitatively in the supernatant solution with little carry-over of⁹⁹Mo. This calcium molybdate (⁹⁹Mo) could be redissolved and reprecipitated at regular intervals, yielding^99mTc quantitatively in aqueous neutral solutions. Calcium molybdate precipitates containing up to 1.5 GBq of⁹⁹Mo and 130–180 mg of molybdenum were prepared and evaluated. The performance in terms of repeated^99mTc separation gave yields of 75–93% with acceptable readionuclidic and radiochemical purity.     

One to chelate them all: investigation of a versatile, bifunctional chelator for 64Cu, 99mTc, Re and Co

We describe the synthesis of the dip (di-picolyl-carboxylate) bifunctional chelator system, capable of fast coordination of Cu(2+), (64)Cu(2+) and Co(2+), as well as the [M(CO)(3)](+)-core (M = (99m)Tc, Re); it displays a variety of binding modes--tridentate when protected, tetradentate when deprotected. Syntheses of both the benzyl-nitro derivative and the benzyl-amino derivatives are described. The latter was coupled to biotin to show the viability of the system for functionalization with biomolecules. Besides coordination chemistry with stable isotopes, we also present labelling data with (64)Cu and (99m)Tc, as well as in vitro stability studies.     

Conjugation of a novel histidine derivative to biomolecules and labelling with [99mTc(OH2)3(CO)3]+

The new histidine derivative 3-[1-[3-(9H-fluoren-9-ylmethoxycarbonylamino)-propyl]-1H-imidazol-4-yl]-2-(3-trimethylsilanyl-ethylcarboxyamino)-propionic acid methyl ester (7) has been prepared via alkylation of the histidine urea derivative (7S)-5,6,7,8-tetrahydro-7-(methoxycarbonyl)-5-oxoimidazo-[1,5-c]-pyrimidine (2) with Fmoc-protected 3-iodopropyl-amine, followed by ring opening with 2-trimethylsilylethanol. After Fmoc cleavage by HNEt2, the histidine amine derivative was coupled to biotin, to the pentapeptide leucine-enkephalin and to Vitamin B12-b-acid by amide formation, employing TBTU as the coupling reagent. In order to make the histidine accessible for labelling, the teoc protecting group was removed by either NBu4F (for the biotin conjugate) or by TFA (for the enkephalin and B12 conjugates). Reaction of a 10(-4) M solution of the bioconjugates with [99mTc(H2O)3(CO)3]+ at 50 degrees C for 30 min led to the formation of one single new peak in the HPLC radiochromatogram in each case, confirming quantitative labelling of the respective biomolecules. To assess the nature of the labelled compounds, the rhenium analogues with Re(CO)3 were also synthesised and similar retention times confirmed the identity with the 99mTc labelled conjugates.     

Rapid and high-yielding cysteine labelling of peptides with N-succinimidyl 4-[18F]fluorobenzoate

Fast cysteine labelling of peptides promoted by an adjacent arginine has been observed with a standard labelling agent specific for amines, N-succinimidyl 4-[(18)F]fluorobenzoate.     

99mTc radiolabeling of crotoxin as a tool for biodistribution studies

Summary Crotoxin (Crtx) is the main toxin of South American rattlesnake (Crotalus durissus terrificus) venom. Research on antitumoral drugs has demonstrated the potential use of Crtx as tumour reducing agent. Tissue distribution studies are very important for clinical use and ^99mTc-labeling is a very convenient method for studies related to biodistribution. The aim of the present study was to label Crtx with ^99mTc keeping its biological activity for use in biodistribution and binding studies. High labeling yield was obtained using stannous chloride and sodium borohydride. Results demonstrated that biological activity of ^99mTc-Crtx was preserved and confirmed kidneys as the target organ. Biological activities of unlabeled and ^99mTc-labeled Crtx were evaluated after labeling. ^99mTc-Crtx can be a useful tool for imaging and binding studies.     

99mTc generator with hydrated MnO2 as adsorbent of 99Mo

An ^99mTc generator with MnO₂ as adsorbent of ⁹⁹Mo was investigated. Through batch experiments the retention of ⁹⁹Mo onto MnO₂was studied as a function of the shaking time and the pH value of the ⁹⁹Mo solution. It was found that ⁹⁹Mo showed a retention of 100% onto MnO₂ at the pH range from 3 to 11, and the equilibrium distribution was reached in less than 10 minutes. In column experiments the retention of ⁹⁹Mo onto MnO₂ was also high: 99.72%. In this case, the pH of the utilized ⁹⁹Mo solution was 5. The ^99mTc could be eluted from the MnO₂-⁹⁹Mo column by using either distilled water with a pH of 5 or an aqueous solution of 0.9% NaCl. With the saline solution, the ^99mTc elution yields were higher than 80%, and only one aliquot of 5 ml was needed to get these yields. The best results were obtained when the column was packed with 1 g of MnO₂. The water and the saline solution were passed through the column at a rate of 1.25 ml/min.     

Labeling of scorpion venom with 99mTc and its biodistribution

Labeling of scorpion venom (SV) was successfully achieved with ^99mTc using direct chelating method. Venom was labeled with ^99mTc using stannous chloride as reducing agent. Preliminary studies were done to establish the optimum conditions for obtaining the highest yield of the labeled venom. The labeling technique is effective, as a maximum labeling yield (97 %) was obtained after 30-min reaction time by using 80 μg SV in phosphate buffer of pH 7 and 25 μg Sncl₂·2H₂O at room temperature. Venom was injected into normal mice to determine the excretion pathway. Biodistribution studies in normal mice with SV shows rapid clearance of the venom from blood and tissue except for kidneys. The improvement of the immunotherapeutic treatment of envenomation requires a better knowledge of the biological actions of the SV since tissue distribution studies are very important for clinical purpose.